Cargando…
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary()
Guidelines for the implantation of cardiac implantable electronic devices (CIEDs) have evolved since publication of the initial ACC/AHA pacemaker guidelines in 1984 [1]. CIEDs have evolved to include novel forms of cardiac pacing, the development of implantable cardioverter defibrillators (ICDs) and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577082/ https://www.ncbi.nlm.nih.gov/pubmed/34333142 http://dx.doi.org/10.1016/j.ipej.2021.07.006 |
_version_ | 1784596005981782016 |
---|---|
author | Silka, Michael J. Shah, Maully J. Avari Silva, Jennifer N. Balaji, Seshadri Beach, Cheyenne M. Benjamin, Monica N. Berul, Charles I. Cannon, Bryan Cecchin, Frank Cohen, Mitchell I. Dalal, Aarti S. Dechert, Brynn E. Foster, Anne Gebauer, Roman Gonzalez Corcia, M. Cecilia Kannankeril, Prince J. Karpawich, Peter P. Kim, Jeffery J. Krishna, Mani Ram Kubuš, Peter LaPage, Martin J. Mah, Douglas Y. Malloy-Walton, Lindsey Miyazaki, Aya Motonaga, Kara S. Niu, Mary C. Olen, Melissa Paul, Thomas Rosenthal, Eric Saarel, Elizabeth V. Silvetti, Massimo Stefano Stephenson, Elizabeth A. Tan, Reina B. Triedman, John Von Bergen, Nicholas H. Wackel, Philip L. |
author_facet | Silka, Michael J. Shah, Maully J. Avari Silva, Jennifer N. Balaji, Seshadri Beach, Cheyenne M. Benjamin, Monica N. Berul, Charles I. Cannon, Bryan Cecchin, Frank Cohen, Mitchell I. Dalal, Aarti S. Dechert, Brynn E. Foster, Anne Gebauer, Roman Gonzalez Corcia, M. Cecilia Kannankeril, Prince J. Karpawich, Peter P. Kim, Jeffery J. Krishna, Mani Ram Kubuš, Peter LaPage, Martin J. Mah, Douglas Y. Malloy-Walton, Lindsey Miyazaki, Aya Motonaga, Kara S. Niu, Mary C. Olen, Melissa Paul, Thomas Rosenthal, Eric Saarel, Elizabeth V. Silvetti, Massimo Stefano Stephenson, Elizabeth A. Tan, Reina B. Triedman, John Von Bergen, Nicholas H. Wackel, Philip L. |
collection | PubMed |
description | Guidelines for the implantation of cardiac implantable electronic devices (CIEDs) have evolved since publication of the initial ACC/AHA pacemaker guidelines in 1984 [1]. CIEDs have evolved to include novel forms of cardiac pacing, the development of implantable cardioverter defibrillators (ICDs) and the introduction of devices for long term monitoring of heart rhythm and other physiologic parameters. In view of the increasing complexity of both devices and patients, practice guidelines, by necessity, have become increasingly specific. In 2018, the ACC/AHA/HRS published Guidelines on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay [2], which were specific recommendations for patients >18 years of age. This age-specific threshold was established in view of the differing indications for CIEDs in young patients as well as size-specific technology factors. Therefore, the following document was developed to update and further delineate indications for the use and management of CIEDs in pediatric patients, defined as ≤21 years of age, with recognition that there is often overlap in the care of patents between 18 and 21 years of age. This document is an abbreviated expert consensus statement (ECS) intended to focus primarily on the indications for CIEDs in the setting of specific disease/diagnostic categories. This document will also provide guidance regarding the management of lead systems and follow-up evaluation for pediatric patients with CIEDs. The recommendations are presented in an abbreviated modular format, with each section including the complete table of recommendations along with a brief synopsis of supportive text and select references to provide some context for the recommendations. This document is not intended to provide an exhaustive discussion of the basis for each of the recommendations, which are further addressed in the comprehensive PACES-CIED document [3], with further data easily accessible in electronic searches or textbooks. |
format | Online Article Text |
id | pubmed-8577082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-85770822021-11-12 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary() Silka, Michael J. Shah, Maully J. Avari Silva, Jennifer N. Balaji, Seshadri Beach, Cheyenne M. Benjamin, Monica N. Berul, Charles I. Cannon, Bryan Cecchin, Frank Cohen, Mitchell I. Dalal, Aarti S. Dechert, Brynn E. Foster, Anne Gebauer, Roman Gonzalez Corcia, M. Cecilia Kannankeril, Prince J. Karpawich, Peter P. Kim, Jeffery J. Krishna, Mani Ram Kubuš, Peter LaPage, Martin J. Mah, Douglas Y. Malloy-Walton, Lindsey Miyazaki, Aya Motonaga, Kara S. Niu, Mary C. Olen, Melissa Paul, Thomas Rosenthal, Eric Saarel, Elizabeth V. Silvetti, Massimo Stefano Stephenson, Elizabeth A. Tan, Reina B. Triedman, John Von Bergen, Nicholas H. Wackel, Philip L. Indian Pacing Electrophysiol J Practical Guideline Guidelines for the implantation of cardiac implantable electronic devices (CIEDs) have evolved since publication of the initial ACC/AHA pacemaker guidelines in 1984 [1]. CIEDs have evolved to include novel forms of cardiac pacing, the development of implantable cardioverter defibrillators (ICDs) and the introduction of devices for long term monitoring of heart rhythm and other physiologic parameters. In view of the increasing complexity of both devices and patients, practice guidelines, by necessity, have become increasingly specific. In 2018, the ACC/AHA/HRS published Guidelines on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay [2], which were specific recommendations for patients >18 years of age. This age-specific threshold was established in view of the differing indications for CIEDs in young patients as well as size-specific technology factors. Therefore, the following document was developed to update and further delineate indications for the use and management of CIEDs in pediatric patients, defined as ≤21 years of age, with recognition that there is often overlap in the care of patents between 18 and 21 years of age. This document is an abbreviated expert consensus statement (ECS) intended to focus primarily on the indications for CIEDs in the setting of specific disease/diagnostic categories. This document will also provide guidance regarding the management of lead systems and follow-up evaluation for pediatric patients with CIEDs. The recommendations are presented in an abbreviated modular format, with each section including the complete table of recommendations along with a brief synopsis of supportive text and select references to provide some context for the recommendations. This document is not intended to provide an exhaustive discussion of the basis for each of the recommendations, which are further addressed in the comprehensive PACES-CIED document [3], with further data easily accessible in electronic searches or textbooks. Elsevier 2021-07-29 /pmc/articles/PMC8577082/ /pubmed/34333142 http://dx.doi.org/10.1016/j.ipej.2021.07.006 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Practical Guideline Silka, Michael J. Shah, Maully J. Avari Silva, Jennifer N. Balaji, Seshadri Beach, Cheyenne M. Benjamin, Monica N. Berul, Charles I. Cannon, Bryan Cecchin, Frank Cohen, Mitchell I. Dalal, Aarti S. Dechert, Brynn E. Foster, Anne Gebauer, Roman Gonzalez Corcia, M. Cecilia Kannankeril, Prince J. Karpawich, Peter P. Kim, Jeffery J. Krishna, Mani Ram Kubuš, Peter LaPage, Martin J. Mah, Douglas Y. Malloy-Walton, Lindsey Miyazaki, Aya Motonaga, Kara S. Niu, Mary C. Olen, Melissa Paul, Thomas Rosenthal, Eric Saarel, Elizabeth V. Silvetti, Massimo Stefano Stephenson, Elizabeth A. Tan, Reina B. Triedman, John Von Bergen, Nicholas H. Wackel, Philip L. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary() |
title | 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary() |
title_full | 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary() |
title_fullStr | 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary() |
title_full_unstemmed | 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary() |
title_short | 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary() |
title_sort | 2021 paces expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: executive summary() |
topic | Practical Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577082/ https://www.ncbi.nlm.nih.gov/pubmed/34333142 http://dx.doi.org/10.1016/j.ipej.2021.07.006 |
work_keys_str_mv | AT 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT silkamichaelj 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT shahmaullyj 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT avarisilvajennifern 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT balajiseshadri 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT beachcheyennem 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT benjaminmonican 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT berulcharlesi 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT cannonbryan 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT cecchinfrank 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT cohenmitchelli 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT dalalaartis 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT dechertbrynne 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT fosteranne 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT gebauerroman 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT gonzalezcorciamcecilia 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT kannankerilprincej 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT karpawichpeterp 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT kimjefferyj 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT krishnamaniram 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT kubuspeter 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT lapagemartinj 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT mahdouglasy 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT malloywaltonlindsey 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT miyazakiaya 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT motonagakaras 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT niumaryc 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT olenmelissa 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT paulthomas 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT rosenthaleric 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT saarelelizabethv 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT silvettimassimostefano 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT stephensonelizabetha 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT tanreinab 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT triedmanjohn 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT vonbergennicholash 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT wackelphilipl 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary AT 2021pacesexpertconsensusstatementontheindicationsandmanagementofcardiovascularimplantableelectronicdevicesinpediatricpatientsexecutivesummary |